Gait‐Related Metabolic Covariance Networks at Rest in Parkinson's Disease

Abstract

Background Gait impairments are characteristic motor manifestations and significant predictors of poor quality of life in Parkinson's disease (PD). Neuroimaging biomarkers for gait impairments in PD could facilitate effective interventions to improve these symptoms and are highly warranted. Objective The aim of this study was to identify neural networks of discrete gait impairments in PD. Methods Fifty‐five participants with early‐stage PD and 20 age‐matched healthy volunteers underwent quantitative gait assessment deriving 12 discrete spatiotemporal gait characteristics and [18F]‐2‐fluoro‐2‐deoxyglucose‐positron emission tomography measuring resting cerebral glucose metabolism. A multivariate spatial covariance approach was used to identify metabolic brain networks that were related to discrete gait characteristics in PD. Results In PD, we identified two metabolic gait‐related covariance networks. The first correlated with mean step velocity and mean step length (pace gait network), which involved relatively increased and decreased metabolism in frontal cortices, including the dorsolateral prefrontal and orbital frontal, insula, supplementary motor area, ventrolateral thalamus, cerebellum, and cuneus. The second correlated with swing time variability and step time variability (temporal variability gait network), which included relatively increased and decreased metabolism in sensorimotor, superior parietal cortex, basal ganglia, insula, hippocampus, red nucleus, and mediodorsal thalamus. Expression of both networks was significantly elevated in participants with PD relative to healthy volunteers and were not related to levodopa dosage or motor severity. Conclusions We have identified two novel gait‐related brain networks of altered glucose metabolism at rest. These gait networks could serve as a potential neuroimaging biomarker of gait impairments in PD and facilitate development of therapeutic strategies for these disabling symptoms. © 2022 The Authors. Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society

MRI biomarkers of freezing of gait development in Parkinson’s disease

“…At baseline, PD-FoG-converters showed higher global and parietal local efficiency and clustering coefficient relative to PD-FoG cases and healthy controls, suggesting an increased functional communication in the parietal network and globally in the brain in PD-FoG-converters. These findings are in line with recent evidence supporting the presence of a cholinergic up-regulation in specific gait control networks (including the parietal lobe) as a compensatory mechanism to counteract aberrant dopaminergic function in PD 35 , 36 . The pattern of increased parietal clustering coefficient might also represent an attempt to compensate for the incremental structural alteration of posterior cortical areas in PD-FoG-converters 34 .…”

Safety and tolerability of adjunct non-invasive vagus nerve stimulation in people with parkinson’s: a study protocol

“…Furthermore, a metabolic temporal variability gait covariance network in PD was recently reported to correlate with variability of step and swing time. This network was characterised by predominantly decreased brain glucose metabolism (associated with increased step and swing time variability) in the caudate nucleus, hippocampus, and red nucleus, which all receive cholinergic input from cell groups within the basal forebrain and the pedunculopontine nucleus (PPN) [11]. Research has shown that the number of acetylcholinesterase + neurons in the PPN is reduced in PD fallers relative to those patients without balance deficits and a history of falls [12].…”